Homology Medicines (FIXX) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free FIXX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 26, 2024 | marketbeat.comTrading was temporarily halted for "FIXX" at 07:03 PM with a stated reason of "News pending."March 24, 2024 | finanznachrichten.deHomology Medicines, Inc.: Homology Medicines Declares Distribution to Common StockholdersMarch 23, 2024 | seekingalpha.comFIXX Homology Medicines, Inc.March 18, 2024 | finance.yahoo.comHomology Medicines Declares Distribution to Common StockholdersFebruary 27, 2024 | businesswire.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXFebruary 2, 2024 | investing.comHomology Medicines Inc (FIXX)January 4, 2024 | finanznachrichten.deHomology Medicines, Inc.: Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyJanuary 4, 2024 | msn.comHomology Medicines gets non-compliance notice from NasdaqJanuary 3, 2024 | finance.yahoo.comHomology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyDecember 27, 2023 | benzinga.comHomology Medicines Stock (NASDAQ:FIXX) Insider TradesDecember 27, 2023 | benzinga.comHomology Medicines Stock (NASDAQ:FIXX), Short Interest ReportNovember 21, 2023 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MIRO, SRC, PATI, FIXXNovember 17, 2023 | businesswire.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXNovember 17, 2023 | businesswire.comHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXNovember 17, 2023 | bizjournals.comBig Pharma-backed startup to go public by merging with gutted HomologyNovember 16, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Homology Medicines (FIXX), Align Tech (ALGN) and Calidi Biotherapeutics (CLDI)November 16, 2023 | msn.comHomology Medicines slumps after merger deal with Q32 BioNovember 16, 2023 | msn.comWhy Is Rare Disease Focused Homology Medicines Stock Trading Lower Today?November 16, 2023 | tmcnet.comFIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to ShareholdersNovember 16, 2023 | marketwatch.comHomology Medicines Shares Drop 38% After Buyout Offer From Q32 BioNovember 16, 2023 | markets.businessinsider.comHomology Medicines To Merge With Q32 Bio; Homology Medicines Down In Pre-marketNovember 16, 2023 | finance.yahoo.comQ32 Bio and Homology Medicines Announce Merger AgreementNovember 15, 2023 | finanznachrichten.deHomology Medicines, Inc.: Homology Medicines Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | msn.comHomology Medicines GAAP EPS of -$0.57 misses by $0.15November 14, 2023 | finance.yahoo.comHomology Medicines Reports Third Quarter 2023 Financial ResultsOctober 28, 2023 | finance.yahoo.comCan Homology Medicines (NASDAQ:FIXX) Afford To Invest In Growth?August 15, 2023 | finanznachrichten.deHomology Medicines, Inc.: Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsAugust 14, 2023 | finance.yahoo.comHomology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsAugust 3, 2023 | msn.comHomology Medicines (FIXX) Price Target Decreased by 55.71% to 3.16July 28, 2023 | bizjournals.comHomology lays off 80, explores sale, citing 'tough financing conditions'July 28, 2023 | msn.comHomology (NASDAQ:FIXX) Mulls Strategic Options; Shares JumpJuly 28, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Homology MedicinesJuly 28, 2023 | finance.yahoo.comHomology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUJuly 28, 2023 | finance.yahoo.comHomology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUJuly 27, 2023 | marketbeat.comTrading was temporarily halted for "FIXX" at 04:07 PM with a stated reason of "News pending."June 22, 2023 | marketwatch.comPhenylketonuria Drugs Market: Trends, Demand, Growth, Business Development, Analysis By 2029June 22, 2023 | markets.businessinsider.comRobert W. Baird Keeps Their Buy Rating on Homology Medicines (FIXX)May 16, 2023 | finance.yahoo.comHomology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingMay 15, 2023 | markets.businessinsider.comHomology Medicines (FIXX) Gets a Hold from RBC CapitalMay 15, 2023 | msn.comHC Wainwright & Co. Reiterates Homology Medicines (FIXX) Buy RecommendationMay 15, 2023 | markets.businessinsider.comRobert W. Baird Sticks to Their Buy Rating for Homology Medicines (FIXX)May 12, 2023 | msn.comChardan Capital Maintains Homology Medicines (FIXX) Buy RecommendationMay 12, 2023 | msn.comCredit Suisse Reiterates Homology Medicines (FIXX) Neutral RecommendationMay 12, 2023 | markets.businessinsider.comCredit Suisse Keeps Their Hold Rating on Homology Medicines (FIXX)May 12, 2023 | finanznachrichten.deHomology Medicines, Inc.: Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsMay 11, 2023 | technews.tmcnet.comHomology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsMay 11, 2023 | seekingalpha.comHomology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21MMay 3, 2023 | tmcnet.comHomology Medicines Announces Upcoming Presentations Highlighting its GeneticMay 3, 2023 | finance.yahoo.comHomology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual MeetingApril 3, 2023 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Homology Medicines (FIXX) Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly. Click here to stream this controversial exposé now. FIXX Media Mentions By Week FIXX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FIXX News Sentiment▼0.000.76▲Average Medical News Sentiment FIXX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FIXX Articles This Week▼00▲FIXX Articles Average Week Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bicycle Therapeutics News Wave Life Sciences News Akebia Therapeutics News RAPT Therapeutics News Spero Therapeutics News Perrigo News Crinetics Pharmaceuticals News Axsome Therapeutics News Merus News Ultragenyx Pharmaceutical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FIXX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Homology Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
